SARS-CoV-2 in patients with chronic liver disease.
作者信息
Hindson Jordan
机构信息
Nature Reviews Gastroenterology & Hepatology, .
出版信息
Nat Rev Gastroenterol Hepatol. 2020 Dec;17(12):714. doi: 10.1038/s41575-020-00384-3.
Abstract
摘要
相似文献
1
SARS-CoV-2 in patients with chronic liver disease.慢性肝病患者中的新型冠状病毒2型
Nat Rev Gastroenterol Hepatol. 2020 Dec;17(12):714. doi: 10.1038/s41575-020-00384-3.
2
COVID-19 and the liver: What do we know after six months of the pandemic?COVID-19 与肝脏：大流行六个月后我们了解多少？
Ann Hepatol. 2020 Nov-Dec;19(6):590-591. doi: 10.1016/j.aohep.2020.09.001. Epub 2020 Sep 18.
3
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel.新型冠状病毒肺炎与肝损伤：肝脏作为这场大流行“新剧”的主角。
Scand J Immunol. 2021 Mar;93(3):e12977. doi: 10.1111/sji.12977. Epub 2020 Sep 26.
4
Digestive and Liver Diseases and the COVID-19 Pandemic.《消化系统与肝脏疾病及新冠疫情》
Dig Liver Dis. 2020 Aug;52(8):799. doi: 10.1016/j.dld.2020.07.006.
5
Assessing the impact of COVID-19 on the management of patients with liver diseases: A national survey by the Italian association for the study of the Liver.评估 COVID-19 对肝病患者管理的影响：意大利肝病研究协会的全国性调查。
Dig Liver Dis. 2020 Sep;52(9):937-941. doi: 10.1016/j.dld.2020.07.008. Epub 2020 Jul 10.
6
Telemedicine, COVID-19 and liver diseases: Revamping remote care initiatives in hepatology.远程医疗、COVID-19与肝脏疾病：重塑肝病学中的远程护理举措
Ann Hepatol. 2020 Jul-Aug;19(4):339-340. doi: 10.1016/j.aohep.2020.05.002. Epub 2020 May 23.
7
SARS-CoV-2 infection in patients with a normal or abnormal liver.肝脏正常或异常患者的新型冠状病毒2型感染
J Viral Hepat. 2021 Jan;28(1):4-11. doi: 10.1111/jvh.13440. Epub 2020 Dec 1.
8
[The protocol for prevention, diagnosis and treatment of liver injury in coronavirus disease 2019].[新型冠状病毒肺炎肝损伤防治专家共识]
Zhonghua Gan Zang Bing Za Zhi. 2020 Mar 20;28(3):217-221. doi: 10.3760/cma.j.cn501113-20200309-00095.
9
Direct or Collateral Liver Damage in SARS-CoV-2-Infected Patients.SARS-CoV-2 感染患者的直接或间接肝损伤。
Semin Liver Dis. 2020 Aug;40(3):321-330. doi: 10.1055/s-0040-1715108. Epub 2020 Sep 4.
10
Clinical insight into the involvement of gut and liver by COVID-19.对2019冠状病毒病累及肠道和肝脏的临床见解。
J Pak Med Assoc. 2020 Jun;70(6):952-953.
引用本文的文献
1
COVID-19, Possible Hepatic Pathways and Alcohol Abuse-What Do We Know up to 2023?2023 年关于 COVID-19、可能的肝脏途径和酒精滥用，我们了解多少？
Int J Mol Sci. 2024 Feb 12;25(4):2212. doi: 10.3390/ijms25042212.
本文引用的文献
1
Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study.慢性肝病患者感染 SARS-CoV-2 后的结局：一项国际注册研究。
J Hepatol. 2021 Mar;74(3):567-577. doi: 10.1016/j.jhep.2020.09.024. Epub 2020 Oct 6.
Zotero 插件